Transcriptional control of the TNF Gene

Current Directions in Autoimmunity

Volumn 11, Issue , 2010, Pages 27-60

  Falvo, James V ^a   Tsytsykova, Alla V ^a   Goldfeld, Anne E ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR NFAT; TUMOR NECROSIS FACTOR;

B LYMPHOCYTE; CHROMATIN STRUCTURE; CYTOKINE PRODUCTION; DENDRITIC CELL; FIBROBLAST; GENE CONTROL; GENE EXPRESSION REGULATION; GENE LOCUS; GENETIC EPIGENESIS; HUMAN; IMMUNOREACTIVITY; IMMUNOREGULATION; MACROPHAGE; MAST CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION REGULATION;

ANIMALS; BASE SEQUENCE; CHROMATIN ASSEMBLY AND DISASSEMBLY; DNA; EPIGENESIS, GENETIC; GENES, IMMEDIATE-EARLY; HUMANS; MICE; MOLECULAR SEQUENCE DATA; NF-KAPPA B; NFATC TRANSCRIPTION FACTORS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77949451757     PISSN: 14222132     EISSN: 16622936     Source Type: Book Series    
DOI: 10.1159/000289196     Document Type: Review

References (261)

1. Aggarwal BB, Samanta A, Feldmann M: TNFα; in Oppenheim J, Feldmann M (eds): Cytokine Reference. Orlando, Academic Press, 2000, pp 413-434.
2. Grivennikov SI, Kuprash DV, Liu ZG, Nedospasov SA: Intracellular signals and events activated by cytokines of the tumor necrosis factor superfamily: from simple paradigms to complex mechanisms. Int Rev Cytol 2006;252:129-161.
3. Beutler B, Cerami A: Cachectin and tumor necrosis factor as two sides of the same biological coin. Nature 1986;320:584.
4. Cuturi MC, Murphy M, Costa-Giomi M P, Weinmann R, Perussia B, Trinchieri G: Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes. J Exp Med 1987;165:1581-1594.
5. Steffen M, Ottmann OG, Moore MA: Simultaneous production of tumor necrosis factor-α and lympho-toxin by normal T cells after induction with IL-2 and anti-T3. J Immunol 1988;140:2621-2624.
6. Sung SS, Bjorndahl JM, Wang CY, Kao HT, Fu SM: Production of tumor necrosis factor/cachectin by human T cell lines and peripheral blood T lymphocytes stimulated by phorbol myristate acetate and anti-CD3 antibody. J Exp Med 1988;167:937-953.
7. Sung SS, Jung LK, Walters JA, Chen W, Wang CY, Fu SM: Production of tumor necrosis factor/cachec-tin by human B cell lines and tonsillar B cells. J Exp Med 1988;168:1539-1551.
8. Niitsu Y, Watanabe N, Neda H, Yamauchi N, Maeda M, Sone H, Kuriyama H: Induction of synthesis of tumor necrosis factor in human and murine cell lines by exogenous recombinant human tumor necrosis factor. Cancer Res 1988;48:5407-5410.
9. Goldfeld AE, Maniatis T: Coordinate viral induction of tumor necrosis factor α and interferon β in human B cells and monocytes. Proc Natl Acad Sci USA 1989;86:1490-1494.
10. Gordon JR, Galli SJ: Mast cells as a source of both preformed and immunologically inducible TNF-α/ cachectin. Nature 1990;346:274-276.
11. Caux C, Massacrier C, Vanbervliet B, Dubois B, Van Kooten C, Durand I, Banchereau J: Activation of human dendritic cells through CD40 cross-linking. J Exp Med 1994;180:1263-1272.
12. Akira S, Takeda K: Toll-like receptor signalling. Nat Rev Immunol 2004;4:499-511.
13. Goldfeld AE, Flemington EK, Boussiotis VA, Theodos CM, Titus RG, Strominger JL, Speck SH: Transcription of the tumor necrosis factor α gene is rapidly induced by anti-immunoglobulin and blocked by cyclosporin A and FK506 in human B cells. Proc Natl Acad Sci USA 1992;89:12198-12201.
14. Goldfeld AE, Strominger JL, Doyle C: Human tumor necrosis factor α gene regulation in phorbol ester stimulated T and B cell lines. J Exp Med 1991; 174:73-81.
15. Goldfeld AE, McCaffrey PG, Strominger JL, Rao A: Identification of a novel cyclosporin-sensitive element in the human tumor necrosis factor α gene promoter. J Exp Med 1993;178:1365-1379.
16. Diehn M, Alizadeh AA, Rando OJ, Liu CL, Stankunas K, Botstein D, Crabtree GR, Brown PO: Genomic expression programs and the integration of the CD28 costimulatory signal in T cell activation. Proc Natl Acad Sci USA 2002;99:11796-11801.
17. Aggarwal BB, Shishodia S, Takada Y, Jackson-Bernitsas D, Ahn KS, Sethi G, Ichikawa H: TNF blockade: an inflammatory issue. Ernst Schering Res Found Workshop 2006:161-186.
18. Sethi G, Sung B, Aggarwal BB: TNF: A master switch for inflammation to cancer. Front Biosci 2008;13:5094-5107.
19. Lou J, Lucas R, Grau GE: Pathogenesis of cerebral malaria: recent experimental data and possible applications for humans. Clin Microbiol Rev 2001; 14:810-820.
20. Jacobs M, Samarina A, Grivennikov S, Botha T, Allie N, Fremond C, Togbe D, Vasseur V, Rose S, Erard F, Monteiro A, Quesniaux V, Ryffel B: Reactivation of tuberculosis by tumor necrosis factor neutralization. Eur Cytokine Netw 2007;18:5-13.
21. Falvo J V, Uglialoro AM, Brinkman BM, Merika M, Parekh BS, Tsai EY, King HC, Morielli AD, Peralta EG, Maniatis T, Thanos D, Goldfeld AE: Stimulus-specific assembly of enhancer complexes on the tumor necrosis factor alpha gene promoter. Mol Cell Biol 2000;20:2239-2247.
22. Tsai EY, Falvo J V, Tsytsykova AV, Barczak AK, Reimold AM, Glimcher LH, Fenton MJ, Gordon DC, Dunn IF, Goldfeld AE: A lipopolysaccharide-specific enhancer complex involving Ets, Elk-1, Sp1, and CREB binding protein and p300 is recruited to the tumor necrosis factor alpha promoter in vivo. Mol Cell Biol 2000;20:6084-6094.
23. Tsytsykova AV, Goldfeld AE: Inducer-specific enhanceosome formation controls tumor necrosis factor alpha gene expression in T lymphocytes. Mol Cell Biol 2002;22:2620-2631.
24. Barthel R, Tsytsykova AV, Barczak AK, Tsai EY, Dascher CC, Brenner MB, Goldfeld AE: Regulation of tumor necrosis factor alpha gene expression by mycobacteria involves the assembly of a unique enhanceosome dependent on the coactivator proteins CBP/p300. Mol Cell Biol 2003;23:526-533.
25. Carey M: The enhanceosome and transcriptional synergy. Cell 1998;92:5-8.
26. Merika M, Thanos D: Enhanceosomes. Curr Opin Genet Dev 2001;11:205-208.
27. Falvo J V, Brinkman BMN, Tsytsykova AV, Tsai EY, Yao T-P, Kung AL, Goldfeld AE: A stimulus-specific role for CREB-binding protein (CBP) in T cell receptor-activated tumor necrosis factor α gene expression. Proc Natl Acad Sci USA 2000;97:3925-3929.
28. Shakhov AN, Collart MA, Vassalli P, Nedospasov SA, Jongeneel CV: κB-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor α gene in primary macrophages. J Exp Med 1990;171:35-47.
29. Kuprash D V, Udalova IA, Turetskaya RL, Kwiat-kowski D, Rice NR, Nedospasov SA: Similarities and differences between human and murine TNF promoters in their response to lipopolysaccharide. J Immunol 1999;162:4045-4052.
30. Goldfeld AE, Leung JY, Sawyer SA, Hartl DL: Post-genomics and the neutral theory: variation and conservation in the tumor necrosis factor-α promoter. Gene 2000;261:19-25.
31. Cross JG, Harrison GA, Coggill P, Sims S, Beck S, Deakin JE, Graves JA: Analysis of the genomic region containing the tammar wallaby (Macropus eugenii) orthologues of MHC class III genes. Cytogenet Genome Res 2005;111:110-117.
32. Leung JY, McKenzie FE, Uglialoro AM, Flores-Villanueva PO, Sorkin BC, Yunis EJ, Hartl DL, Goldfeld AE: Identification of phylogenetic footprints in primate tumor necrosis factor-α promoters. Proc Natl Acad Sci USA 2000;97:6614-6618.
33. Baena A, Mootnick AR, Falvo J V, Tsytskova AV, Ligeiro F, Diop OM, Brieva C, Gagneux P, O'Brien SJ, Ryder OA, Goldfeld AE: Primate TNF promoters reveal markers of phylogeny and evolution of innate immunity. PLoS One 2007;2:e621.
34. Tsai EY, Jain J, Pesavento PA, Rao A, Goldfeld AE: Tumor necrosis factor alpha gene regulation in activated T cells involves ATF-2/Jun and NFATp. Mol Cell Biol 1996;16:459-467.
35. Tsai EY, Yie J, Thanos D, Goldfeld AE: Cell-type-specific regulation of the human tumor necrosis factor alpha gene in B cells and T cells by NFATp and ATF-2/JUN. Mol Cell Biol 1996;16:5232-5244.
36. Tsytsykova AV, Goldfeld AE: Nuclear factor of activated T cells transcription factor NFATp controls superantigen-induced lethal shock. J Exp Med 2000; 192:581-586.
37. Goldfeld AE, Doyle C, Maniatis T: Human tumor necrosis factor α gene regulation by virus and lipopolysaccharide. Proc Natl Acad Sci USA 1990; 87:9769-9773.
38. Trede NS, Tsytsykova AV, Chatila T, Goldfeld AE, Geha RS: Transcriptional activation of the human TNF-α promoter by superantigen in human mono-cytic cells: role of NF-κB. J Immunol 1995;155:902-908.
39. Yao J, Mackman N, Edgington TS, Fan ST: Lipopolysaccharide induction of the tumor necrosis factor-α promoter in human monocytic cells. Regulation by Egr-1, c-Jun, and NF-κB transcription factors. J Biol Chem 1997;272:17795-17801.
40. Haudek SB, Natmeβnig BE, Redl H, Schlag G, Giroir BP: Genetic sequences and transcriptional regulation of the TNFA promoter: comparison of human and baboon. Immunogenetics 1998;48:202-207.
41. Means TK, Pavlovich R P, Roca D, Vermeulen M W, Fenton MJ: Activation of TNF-α transcription utilizes distinct MAP kinase pathways in different macrophage populations. J Leukoc Biol 2000;67:885-893.
42. O'Donnell PM, Taffet SM: The proximal promoter region is essential for lipopolysaccharide induction and cyclic AMP inhibition of mouse tumor necrosis factor-α. J Interferon Cytokine Res 2002;22:539-548.
43. Leitman DC, Mackow ER, Williams T, Baxter JD, West BL: The core promoter region of the tumor necrosis factor α gene confers phorbol ester responsiveness to upstream transcriptional activators. Mol Cell Biol 1992;12:1352-1356.
44. Brinkman BM, Telliez JB, Schievella AR, Lin LL, Goldfeld AE: Engagement of tumor necrosis factor (TNF) receptor 1 leads to ATF-2-and p38 mitogen-activated protein kinase-dependent TNF-α gene expression. J Biol Chem 1999;274:30882-30886.
45. Esensten JH, Tsytsykova AV, Lopez-Rodriguez C, Ligeiro FA, Rao A, Goldfeld AE: NFAT5 binds to the TNF promoter distinctly from NFATp, c, 3 and 4, and activates TNF transcription during hyper-tonic stress alone. Nucleic Acids Res 2005;33:3845-3854.
46. Economou JS, Rhoades K, Essner R, McBride WH, Gasson JC, Morton DL: Genetic analysis of the human tumor necrosis factor α/cachectin promoter region in a macrophage cell line. J Exp Med 1989; 170:321-326.
47. Rhoades KL, Golub SH, Economou JS: The regulation of the human tumor necrosis factor α promoter region in macrophage, T cell, and B cell lines. J Biol Chem 1992;267:22102-22107.
48. McCaffrey PG, Goldfeld AE, Rao A: The role of NFATp in cyclosporin A-sensitive tumor necrosis factor-α gene transcription. J Biol Chem 1994;269: 30445-30450.
49. Krämer B, Wiegmann K, Krönke M: Regulation of the human TNF promoter by the transcription factor Ets. J Biol Chem 1995;270:6577-6583.
50. Krämer B, Meichle A, Hensel G, Charnay P, Krönke M: Characterization of an Krox-24/Egr-1-responsive element in the human tumor necrosis factor promoter. Biochim Biophys Acta 1994;1219:413-421.
51. Leitman DC, Ribeiro RC, Mackow ER, Baxter JD, West BL: Identification of a tumor necrosis factor-responsive element in the tumor necrosis factor α gene. J Biol Chem 1991;266:9343-9346.
52. Falvo J V, Lin CH, Tsytsykova AV, Hwang PK, Thanos D, Goldfeld AE, Maniatis T: A dimer-spe-cific function of the transcription factor NFATp. Proc Natl Acad Sci USA 2008.
53. Newell CL, Deisseroth AB, Lopez-Berestein G: Interaction of nuclear proteins with an AP-1/CRE-like promoter sequence in the human TNF-α gene. J Leukoc Biol 1994;56:27-35.
54. Diaz B, Lopez-Berestein G: A distinct element involved in lipopolysaccharide activation of the tumor necrosis factor-α promoter in monocytes. J Interferon Cytokine Res 2000;20:741-748.
55. Steer JH, Kroeger KM, Abraham LJ, Joyce DA: Glucocorticoids suppress tumor necrosis factor-α expression by human monocytic THP-1 cells by suppressing transactivation through adjacent NF-κB and c-Jun-activating transcription factor-2 binding sites in the promoter. J Biol Chem 2000;275:18432-18440.
56. Sato H, Watanabe A, Tanaka T, Koitabashi N, Arai M, Kurabayashi M, Yokoyama T: Regulation of the human tumor necrosis factor-α promoter by angio-tensin II and lipopolysaccharide in cardiac fibro-blasts: different cis-acting promoter sequences and transcriptional factors. J Mol Cell Cardiol 2003; 35:1197-1205.
57. Hayakawa J, Mittal S, Wang Y, Korkmaz KS, Adamson E, English C, Ohmichi M, McClelland M, Mercola D: Identification of promoters bound by c-Jun/ATF2 during rapid large-scale gene activation following genotoxic stress. Mol Cell 2004;16:521-535.
58. Hogan PG, Chen L, Nardone J, Rao A: Transcrip-tional regulation by calcium, calcineurin, and NFAT. Genes Dev 2003;17:2205-2232.
59. Macian F: NFAT proteins: Key regulators of T-cell development and function. Nat Rev Immunol 2005; 5:472-484.
60. Aramburu J, Drews-Elger K, Estrada-Gelonch A, Minguillón J, Morancho B, Santiago V, López-Rodríguez C: Regulation of the hypertonic stress response and other cellular functions by the Rel-like transcription factor NFAT5. Biochem Pharmacol 2006;72:1597-1604.
61. Wu H, Peisley A, Graef IA, Crabtree GR: NFAT signaling and the invention of vertebrates. Trends Cell Biol 2007;17:251-260.
62. Ullman KS, Northrop J P, Verweij CL, Crabtree GR: Transmission of signals from the T lymphocyte antigen receptor to the genes responsible for cell proliferation and immune function: the missing link. Annu Rev Immunol 1990;8:421-452.
63. McCaffrey PG, Luo C, Kerppola TK, Jain J, Badalian TM, Ho AM, Burgeon E, Lane WS, Lambert JN, Curran T, Verdine GL, Rao A, Hogan PG: Isolation of the cyclosporin-sensitive T cell transcription factor NFATp. Science 1993;262:750-754.
64. Goldfeld AE, Tsai E, Kincaid R, Belshaw PJ, Schreiber SL, Strominger JL, Rao A: Calcineurin mediates human tumor necrosis factor α gene induction in stimulated T and B cells. J Exp Med 1994;180:763-768.
65. Prieschl EE, Gouilleux-Gruart V, Walker C, Harrer NE, Baumruker T: A nuclear factor of activated T cell-like transcription factor in mast cells is involved in IL-5 gene regulation after IgE plus antigen stimulation. J Immunol 1995;154:6112-6119.
66. Klein M, Klein-Hessling S, Palmetshofer A, Serfling E, Tertilt C, Bopp T, Heib V, Becker M, Taube C, Schild H, Schmitt E, Stassen M: Specific and redundant roles for NFAT transcription factors in the expression of mast cell-derived cytokines. J Immunol 2006;177:6667-6674.
67. Kaminuma O, Kitamura F, Kitamura N, Hiroi T, Miyoshi H, Miyawaki A, Miyatake S: Differential contribution of NFATc2 and NFATc1 to TNF-α gene expression in T cells. J Immunol 2008;180:319-326.
68. Song L, Li J, Ye J, Yu G, Ding J, Zhang D, Ouyang W, Dong Z, Kim SO, Huang C: p85α acts as a novel signal transducer for mediation of cellular apoptotic response to UV radiation. Mol Cell Biol 2007;27: 2713-2731.
69. Ke Q, Li J, Ding J, Ding M, Wang L, Liu B, Costa M, Huang C: Essential role of ROS-mediated NFAT activation in TNF-α induction by crystalline silica exposure. Am J Physiol Lung Cell Mol Physiol 2006; 291:L257-264.
70. Ouyang W, Hu Y, Li J, Ding M, Lu Y, Zhang D, Yan Y, Song L, Qu Q, Desai D, Amin S, Huang C: Direct evidence for the critical role of NFAT3 in benzo[a] pyrene diol-epoxide-induced cell transformation through mediation of inflammatory cytokine TNF induction in mouse epidermal Cl41 cells. Carcinogenesis 2007;28:2218-2226.
71. López-Rodriguez C, Aramburu J, Jin L, Rakeman AS, Michino M, Rao A: Bridging the NFAT and NF-κB families: NFAT5 dimerization regulates cytokine gene transcription in response to osmotic stress. Immunity 2001;15:47-58.
72. Hodge MR, Ranger AM, Charles de la Brousse F, Hoey T, Grusby MJ, Glimcher LH: Hyperproliferation and dysregulation of IL-4 expression in NF-ATp-deficient mice. Immunity 1996;4:397-405.
73. Tsytsykova AV, Rajsbaum R, Falvo J V, Ligeiro F, Neely SR, Goldfeld AE: Activation-dependent intra-chromosomal interactions formed by the TNF gene promoter and two distal enhancers. Proc Natl Acad Sci USA 2007;104:16850-16855.
74. Ranger AM, Hodge MR, Gravallese EM, Oukka M, Davidson L, Alt F W, de la Brousse FC, Hoey T, Grusby M, Glimcher LH: Delayed lymphoid repop-ulation with defects in IL-4-driven responses produced by inactivation of NF-ATc. Immunity 1998; 8:125-134.
75. Yoshida H, Nishina H, Takimoto H, Marengere LE, Wakeham AC, Bouchard D, Kong YY, Ohteki T, Shahinian A, Bachmann M, Ohashi PS, Penninger JM, Crabtree GR, Mak TW: The transcription factor NF-ATc1 regulates lymphocyte proliferation and Th2 cytokine production. Immunity 1998;8:115-124.
76. Ranger AM, Oukka M, Rengarajan J, Glimcher LH: Inhibitory function of two NFAT family members in lymphoid homeostasis and Th2 development. Immunity 1998;9:627-635.
77. Peng SL, Gerth AJ, Ranger AM, Glimcher LH: NFATc1 and NFATc2 together control both T and B cell activation and differentiation. Immunity 2001; 14:13-20.
78. Pan M, Winslow MM, Chen L, Kuo A, Felsher D, Crabtree GR: Enhanced NFATc1 nuclear occupancy causes T cell activation independent of CD28 costimulation. J Immunol 2007;178:4315-4321.
79. + T cells. J Immunol 2003; 170:3109-3117.
80. Feske S, Muller JM, Graf D, Kroczek RA, Drager R, Niemeyer C, Baeuerle PA, Peter HH, Schlesier M: Severe combined immunodeficiency due to defective binding of the nuclear factor of activated T cells in T lymphocytes of two male siblings. Eur J Immunol 1996;26:2119-2126.
81. Trifari S, Sitia G, Aiuti A, Scaramuzza S, Marangoni F, Guidotti LG, Martino S, Saracco P, Notarangelo LD, Roncarolo MG, Dupre L: Defective Th1 cytokine gene transcription in CD4+ and CD8+ T cells from Wiskott-Aldrich syndrome patients. J Immunol 2006;177:7451-7461.
82. Perkins ND: Integrating cell-signalling pathways with NF-κB and IKK function. Nat Rev Mol Cell Biol 2007;8:49-62.
83. Hayden MS, Ghosh S: Shared principles in NF-κB signaling. Cell 2008;132:344-362.
84. Vallabhapurapu S, Karin M: Regulation and function of NF-κB transcription factors in the immune system. Annu Rev Immunol 2009;27:693-733.
85. Collart MA, Baeuerle P, Vassalli P: Regulation of tumor necrosis factor alpha transcription in mac-rophages: involvement of four κB-like motifs and of constitutive and inducible forms of NF-κB. Mol Cell Biol 1990;10:1498-1506.
86. Drouet C, Shakhov AN, Jongeneel CV: Enhancers and transcription factors controlling the inducibility of the tumor necrosis factor-α promoter in primary macrophages. J Immunol 1991;147: 1694-1700.
87. Udalova IA, Knight JC, Vidal V, Nedospasov SA, Kwiatkowski D: Complex NF-κB interactions at the distal tumor necrosis factor promoter region in human monocytes. J Biol Chem 1998;273:21178-21186.
88. Ziegler-Heitbrock H W, Sternsdorf T, Liese J, Belohradsky B, Weber C, Wedel A, Schreck R, Bauerle P, Strobel M: Pyrrolidine dithiocarbamate inhibits NF-κB mobilization and TNF production in human monocytes. J Immunol 1993;151:6986-6993.
89. Foxwell B, Browne K, Bondeson J, Clarke C, de Martin R, Brennan F, Feldmann M: Efficient adeno-viral infection with IκBα reveals that macrophage tumor necrosis factor α production in rheumatoid arthritis is NF-κB dependent. Proc Natl Acad Sci USA 1998;95:8211-8215.
90. O'Connell MA, Bennett BL, Mercurio F, Manning AM, Mackman N: Role of IKK1 and IKK2 in lipopolysaccharide signaling in human monocytic cells. J Biol Chem 1998;273:30410-30404.
91. Bondeson J, Browne KA, Brennan FM, Foxwell BMJ,Feldmann M: Selective regulation of cytokine induction by adenoviral gene transfer of IκBα into human macrophages: lipopolysaccharide-induced, but not zymosan-induced proinflammatory cytok-ines are inhibited, but IL-10 is nuclear factor-κB independent. J Immunol 1999;162:2939-2945.
92. Swantek JL, Christerson L, Cobb MH: Lipopoly-saccharide-induced tumor necrosis factor-α promoter activity is inhibitor of nuclear factor-κB kinase-dependent. J Biol Chem 1999;274: 11667-11671.
93. Moore F, Buonocore S, Aksoy E, Ouled-Haddou N, Goriely S, Lazarova E, Paulart F, Heirman C, Vaeremans E, Thielemans K, Goldman M, Flamand V: An alternative pathway of NF-κB activation results in maturation and T cell priming activity of dendritic cells overexpressing a mutated IκBα. J Immunol 2007;178:1301-1311.
94. Hall G, Singh IS, Hester L, Hasday JD, Rogers TB: Inhibitor-κB kinase-β regulates LPS-induced TNF-α production in cardiac myocytes through modulation of NF-κB p65 subunit phosphorylation. Am J Physiol Heart Circ Physiol 2005;289:H2103-H2111.
95. Lim CA, Yao F, Wong JJ, George J, Xu H, Chiu KP, Sung WK, Lipovich L, Vega VB, Chen J, Shahab A, Zhao XD, Hibberd M, Wei CL, Lim B, Ng HH, Ruan Y, Chin KC: Genome-wide mapping of RELA(p65) binding identifies E2F1 as a transcriptional activator recruited by NF-κB upon TLR4 activation. Mol Cell 2007;27:622-635.
96. Maniatis T, Falvo J V, Kim TH, Kim TK, Lin CH, Parekh BS, Wathelet MG: Structure and function of the interferon-β enhanceosome. Cold Spring Harbor Symp Quant Biol 1998;63:609-620.
97. Liu H, Sidiropoulos P, Song G, Pagliari LJ, Birrer MJ, Stein B, Anrather J, Pope RM: TNF-α gene expression in macrophages: regulation by NF-κB is independent of c-Jun or C/EBPβ. J Immunol 2000; 164:4277-4285.
98. Weih F, Warr G, Yang H, Bravo R: Multifocal defects in immune responses in RelB-deficient mice. J Immunol 1997;158:5211-5218.
99. Ye J, Wang L, Zhang X, Tantishaiyakul V, Rojanasakul Y: Inhibition of TNF-α gene expression and bioac-tivity by site-specific transcription factor-binding oligonucleotides. Am J Physiol Lung Cell Mol Physiol 2003;284:L386-394.
100. Joyce DA, Gimblett G, Steer JH: Targets of gluco-corticoid action on TNF-α release by macrophages. Inflamm Res 2001;50:337-340.
101. Xu Z, Dziarski R, Wang Q, Swartz K, Sakamoto KM, Gupta D: Bacterial peptidoglycan-induced tnf-α transcription is mediated through the transcription factors Egr-1, Elk-1, and NF-κB. J Immunol 2001; 167:6975-6982.
102. Tzagarakis-Foster C, Geleziunas R, Lomri A, An J, Leitman DC: Estradiol represses human T-cell leukemia virus type 1 Tax activation of tumor necrosis factor-α gene transcription. J Biol Chem 2002;277: 44772-44777.
103. Tsytsykova AV, Falvo J V, Schmidt-Supprian M, Courtois G, Thanos D, Goldfeld AE: Post-induction, stimulus-specific regulation of tumor necrosis factor mRNA expression. J Biol Chem 2007;282:11629-11638.
104. Kunsch C, Ruben SM, Rosen CA: Selection of optimal κB/Rel DNA-binding motifs: Interaction of both subunits of NF-κB with DNA is required for transcriptional activation. Mol Cell Biol 1992;12: 4412-4421.
105. Bonizzi G, Karin M: The two NF-κB activation pathways and their role in innate and adaptive immunity. Trends Immunol 2004;25:280-288.
106. Natoli G, Saccani S, Bosisio D, Marazzi I: Interactions of NF-κB with chromatin: the art of being at the right place at the right time. Nat Immunol 2005; 6:439-445.
107. Natoli G: Tuning up inflammation: how DNA sequence and chromatin organization control the induction of inflammatory genes by NF-κB. FEBS Lett 2006;580:2843-2849.
108. Orlando V: Mapping chromosomal proteins in vivo by formaldehyde- crosslinked-chromatin immuno-precipitation. Trends Biochem Sci 2000;25:99-104.
109. Litt MD, Simpson M, Gaszner M, Allis CD, Felsenfeld G: Correlation between histone lysine methylation and developmental changes at the chicken β-globin locus. Science 2001;293:2453-2455.
110. Martone R, Euskirchen G, Bertone P, Hartman S, Royce TE, Luscombe NM, Rinn JL, Nelson FK, Miller P, Gerstein M, Weissman S, Snyder M: Distribution of NF-κB-binding sites across human chromosome 22. Proc Natl Acad Sci USA 2003;100: 12247-12252.
111. Bonizzi G, Bebien M, Otero DC, Johnson-Vroom KE, Cao Y, Vu D, Jegga AG, Aronow BJ, Ghosh G, Rickert RC, Karin M: Activation of IKKα target genes depends on recognition of specific κB binding sites by RelB:P52 dimers. EMBO J 2004;23:4202-4210.
112. Taggart CC, Cryan SA, Weldon S, Gibbons A, Greene CM, Kelly E, Low TB, O'Neill S J, McElvaney NG: Secretory leucoprotease inhibitor binds to NF-κB binding sites in monocytes and inhibits p65 binding. J Exp Med 2005;202:1659-1668.
113. Ishinaga H, Jono H, Lim JH, Kweon SM, Xu H, Ha UH, Xu H, Koga T, Yan C, Feng XH, Chen LF, Li JD: TGF-β induces p65 acetylation to enhance bacteria-induced NF-κB activation. EMBO J 2007;26:1150-1162.
114. Carmody RJ, Ruan Q, Palmer S, Hilliard B, Chen YH: Negative regulation of toll-like receptor signaling by NF-κB p50 ubiquitination blockade. Science 2007;317:675-678.
115. El Gazzar MA, El Mezayen R, Nicolls MR, Dreskin SC: Thymoquinone attenuates proinflammatory responses in lipopolysaccharide-activated mast cells by modulating NF-kappaB nuclear transactivation. Biochim Biophys Acta 2007;1770:556-564.
116. Li Y Reddy MA, Miao F, Shanmugam N, Yee JK, Hawkins D, Ren B, Natarajan R: Role of the histone H3 lysine 4 methyltransferase, SET7/9, in the regulation of NF-κB-dependent inflammatory genes. Relevance to diabetes and inflammation. J Biol Chem 2008;283:26771-26781.
117. Buckley JM, Wang JH, Redmond HP: Cellular reprogramming by Gram-positive bacterial components: a review. J Leukoc Biol 2006;80:731-741.
118. Baer M, Dillner A, Schwartz RC, Sedon C, Nedospasov S, Johnson PF: Tumor necrosis factor alpha transcription in macrophages is attenuated by an autocrine factor that preferentially induces NF-κB p50. Mol Cell Biol 1998;18:5678-5689.
119. Frankenberger M, Ziegler-Heitbrock HW: LPS tolerance in monocytes/macrophages: three 3′ cyto-sins are required in the DNA binding motif for detection of upregulated NF-κB p50 homodimers. Immunobiology 1997;198:81-90.
120. Wedel A, Frankenberger M, Sulski G, Petersmann I, Kuprash D, Nedospasov S, Ziegler-Heitbrock HW: Role of p52 (NF-κB2) in LPS tolerance in a human B cell line. Biol Chem 1999;380:1193-1199.
121. Bohuslav J, Kravchenko V V, Parry GC, Erlich JH, Gerondakis S, Mackman N, Ulevitch RJ: Regulation of an essential innate immune response by the p50 subunit of NF-κB. J Clin Invest 1998;102:1645-1652.
122. Wessells J, Baer M, Young HA, Claudio E, Brown K, Siebenlist U, Johnson PF: BCL-3 and NF-κB p50 attenuate lipopolysaccharide-induced inflammatory responses in macrophages. J Biol Chem 2004;279: 49995-50003.
123. El Gazzar M, Yoza BK, Hu JY, Cousart SL, McCall CE: Epigenetic silencing of tumor necrosis factor α during endotoxin tolerance. J Biol Chem 2007;282: 26857-26864.
124. Pope RM, Leutz A, Ness SA: C/EBPβ regulation of the tumor necrosis factor α gene. J Clin Invest 1994; 94:1449-1455.
125. Wedel A, Sulski G, Ziegler-Heitbrock HW: CCAAT/ enhancer binding protein is involved in the expression of the tumour necrosis factor gene in human monocytes. Cytokine 1996;8:335-341.
126. Zagariya A, Mungre S, Lovis R, Birrer M, Ness S, Thimmapaya B, Pope R: Tumor necrosis factor alpha gene regulation: enhancement of C/EBPβ-induced activation by c-Jun. Mol Cell Biol 1998; 18:2815-2824.
127. Tanaka T, Akira S, Yoshida K, Umemoto M, Yoneda Y, Shirafuji N, Fujiwara H, Suematsu S, Yoshida N, Kishimoto T: Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages. Cell 1995; 80:353-361.
128. Gorgoni B, Maritano D, Marthyn P, Righi M, Poli V: C/EBPβ gene inactivation causes both impaired and enhanced gene expression and inverse regulation of IL-12 p40 and p35 mRNAs in macrophages. J Immunol 2002;168:4055-4062.
129. Lu YC, Kim I, Lye E, Shen F, Suzuki N, Suzuki S, Gerondakis S, Akira S, Gaffen SL, Yeh WC, Ohashi PS: Differential role for c-Rel and C/EBPβ/δ in TLR-mediated induction of proinflammatory cytokines. J Immunol 2009;182:7212-7221.
130. Novotny V, Prieschl EE, Csonga R, Fabjani G, Baumruker T: Nrf1 in a complex with fosB, c-jun, junD and ATF2 forms the AP1 component at the TNFα promoter in stimulated mast cells. Nucleic Acids Res 1998;26:5480-5485.
131. Prieschl EE, Novotny V, Csonga R, Jaksche D, Elbe-Burger A, Thumb W, Auer M, Stingl G, Baumruker T: A novel splice variant of the transcription factor Nrf1 interacts with the TNFα promoter and stimulates transcription. Nucleic Acids Res 1998;26:2291-2297.
132. Takagi K, Takagi M, Kanangat S, Warrington KJ, Shigemitsu H, Postlethwaite AE: Modulation of TNF-α gene expression by IFN-γ and pamidronate in murine macrophages: regulation by STAT1-dependent pathways. J Immunol 2005;174:1801-1810.
133. Chappell VL, Le LX, LaGrone L, Mileski WJ: Stat proteins play a role in tumor necrosis factor ααgene expression. Shock 2000;14:400-402; discussion 402-403.
134. Kamezaki K, Shimoda K, Numata A, Matsuda T, Nakayama K, Harada M: The role of Tyk2, Stat1 and Stat4 in LPS-induced endotoxin signals. Int Immunol 2004;16:1173-1179.
135. Myokai F, Takashiba S, Lebo R, Amar S: A novel lipopolysaccharide-induced transcription factor regulating tumor necrosis factor α gene expression: molecular cloning, sequencing, characterization, and chromosomal assignment. Proc Natl Acad Sci USA 1999;96:4518-4523.
136. Bolcato-Bellemin A-L, Mattei M-G, Fenton M, Amar S: Molecular cloning and characterization of mouse LITAF cDNA: role in the regulation of tumor necrosis factor-α (TNF-α) gene expression. J Endo-toxin Res 2004;10:15-23.
137. Tang X, Fenton MJ, Amar S: Identification and functional characterization of a novel binding site on TNF-α promoter. Proc Natl Acad Sci USA 2003; 100:4096-4101.
138. Tang X, Marciano DL, Leeman SE, Amar S: LPS induces the interaction of a transcription factor, LPS-induced TNF-α factor, and STAT6(B) with effects on multiple cytokines. Proc Natl Acad Sci USA 2005;102:5132-5137.
139. Tang X, Metzger D, Leeman S, Amar S: LPS-induced TNF-α factor (LITAF)-deficient mice express reduced LPS-induced cytokine: evidence for LITAF-dependent LPS signaling pathways. Proc Natl Acad Sci USA 2006;103:13777-13782.
140. Vila-del Sol V, Punzón C, Fresno M: IFN-γ-induced TNF-α expression is regulated by interferon regulatory factors 1 and 8 in mouse macrophages. J Immunol 2008;181:4461-4470.
141. Zhao XJ, Dong Q, Bindas J, Piganelli JD, Magill A, Reiser J, Kolls JK: TRIF and IRF-3 binding to the TNF promoter results in macrophage TNF dysregu-lation and steatosis induced by chronic ethanol. J Immunol 2008;181:3049-3056.
142. Covert M W, Leung TH, Gaston JE, Baltimore D: Achieving stability of lipopolysaccharide-induced NF-κB activation. Science 2005;309:1854-1857.
143. Werner SL, Barken D, Hoffmann A: Stimulus specificity of gene expression programs determined by temporal control of IKK activity. Science 2005;309: 1857-1861.
144. Mungall AJ, Palmer SA, Sims SK, et al: The DNA sequence and analysis of human chromosome 6. Nature 2003;425:805-811.
145. Horton R, Wilming L, Rand V, Lovering RC, Bruford EA, Khodiyar VK, Lush MJ, Povey S, Talbot CC Jr, Wright M W, Wain HM, Trowsdale J, Ziegler A, Beck S: Gene map of the extended human MHC. Nat Rev Genet 2004;5:889-899.
146. Allen RD: Polymorphism of the human TNF-α promoter - random variation or functional diversity? Mol Immunol 1999;36:1017-1027.
147. Hajeer AH, Hutchinson IV: TNF-α gene polymorphism: clinical and biological implications. Microsc Res Tech 2000;50:216-228.
148. Hajeer AH, Hutchinson IV: Influence of TNFα gene polymorphisms on TNFα production and disease. Hum Immunol 2001;62:1191-1199.
149. Bayley J-P, Ottenhoff TH, Verweij CL: Is there a future for TNF promoter polymorphisms? Genes Immun 2004;5:315-329.
150. Smith AJ, Humphries SE: Cytokine and cytokine receptor gene polymorphisms and their functionality. Cytokine Growth Factor Rev 2009;20:43-59.
151. Uglialoro AM, Turbay D, Pesavento PA, Delgado JC, McKenzie FE, Gribben JG, Hartl D, Yunis EJ, Goldfeld AE: Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-α gene promoter. Tissue Antigens 1998;52:359-367.
152. Hollegaard MV, Bidwell JL: Cytokine gene polymorphism in human disease: On-line databases, supplement 3. Genes Immun 2006;7:269-276.
153. Wilson AG, de Vries N, Pociot F, di Giovine FS, van der Putte LBA, Duff GW: An allelic polymorphism within the human tumor necrosis factor1α promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med 1993;177:557-560.
154. Higuchi T Seki N, Kamizono S, Yamada A, Kimura A, Kato H, Itoh K: Polymorphism of the 5′-flanking region of the human tumor necrosis factor (TNF)-α gene in Japanese. Tissue Antigens 1998;51:605-612.
155. Baena A, Leung JY, Sullivan AD, Landires I, Vasquez-Luna N, Quinones-Berrocal J, Fraser PA, Uko GP, Delgado JC, Clavijo OP, Thim S, Meshnick SR, Nyirenda T, Yunis EJ, Goldfeld AE: TNF-α promoter single nucleotide polymorphisms are markers of human ancestry. Genes Immun 2002;3: 482-487.
156. Alper CA, Awdeh ZL, Raum DD, Yunis EJ: Extended major histocompatibility complex haplotypes in man: role of alleles analogous to murine τ mutants. Clin Immunol Immunopathol 1982;24:276-285.
157. Yunis EJ, Larsen CE, Fernandez-Vina M, Awdeh ZL, Romero T, Hansen JA, Alper CA: Inheritable variable sizes of DNA stretches in the human MHC: conserved extended haplotypes and their fragments or blocks. Tissue Antigens 2003;62:1-20.
158. Braun N, Michel U, Ernst BP, Metzner R, Bitsch A, Weber F, Rieckmann P: Gene polymorphism at position-308 of the tumor-necrosis-factor-α (TNF-α) in multiple sclerosis and it's influence on the regulation of TNF-α production. Neurosci Lett 1996; 215:75-78.
159. Wu WS, McClain KL: DNA polymorphisms and mutations of the tumor necrosis factor-α (TNF-α) promoter in Langerhans cell histiocytosis (LCH). J Interferon Cytokine Res 1997;17:631-635.
160. Kroeger KM, Carville KS, Abraham LJ: The -308 tumor necrosis factor-α promoter polymorphism effects transcription. Mol Immunol 1997;34:391-399.
161. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW: Effects of a polymorphism in the human tumor necrosis factor α promoter on tran-scriptional activation. Proc Natl Acad Sci USA 1997; 94:3195-3199.
162. Kroeger KM, Steer JH, Joyce DA, Abraham LJ: Effects of stimulus and cell type on the expression of the-308 tumour necrosis factor promoter polymorphism. Cytokine 2000;12:110-119.
163. Brinkman BM, Zuijdeest D, Kaijzel EL, Breedveld FC, Verweij CL: Relevance of the tumor necrosis factor alpha (TNF α) -308 promoter polymorphism in TNF-α gene regulation. J Inflamm 1996;46:32-41.
164. Stuber F, Udalova IA, Book M, Drutskaya LN, Kuprash D V, Turetskaya RL, Schade FU, Nedospasov SA: -308 tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promoter. J Inflamm 1995;46:42-50.
165. Bayley J-P, de Rooij H, van den Elsen PJ, Huizinga T W, Verweij CL: Functional analysis of linker-scan mutants spanning the -376, -308, -244, and -238 polymorphic sites of the TNF-α promoter. Cytokine 2001;14:316-323.
166. Knight JC, Keating BJ, Rockett KA, Kwiatkowski DP: In vivo characterization of regulatory polymorphisms by allele-specific quantification of RNA polymerase loading. Nat Genet 2003;33:469-475.
167. Knight JC, Udalova I, Hill AV, Greenwood BM, Peshu N, Marsh K, Kwiatkowski D: A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nat Genet 1999;22:145-150.
168. Hohjoh H, Tokunaga K: Allele-specific binding of the ubiquitous transcription factor OCT-1 to the functional single nucleotide polymorphism (SNP) sites in the tumor necrosis factor-alpha gene (TNFA) promoter. Genes Immun 2001;2:105-109.
169. van Heel DA, Udalova IA, De Silva A P, McGovern D P, Kinouchi Y, Hull J, Lench NJ, Cardon LR, Carey AH, Jewell D P, Kwiatkowski D: Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF-κB transcription factors. Hum Mol Genet 2002;11:1281-1289.
170. Skoog T, Hamsten A, Eriksson P: Allele-specific chromatin remodeling of the tumor necrosis factor-α promoter. Biochem Biophys Res Commun 2006;351:777-783.
171. Udalova IA, Richardson A, Denys A, Smith C, Ackerman H, Foxwell B, Kwiatkowski D: Functional consequences of a polymorphism affecting NF-κB p50-p50 binding to the TNF promoter region. Mol Cell Biol 2000;20:9113-9119.
172. Kaijzel EL, van Krugten M V, Brinkman BM, Huizinga T W, van der Straaten T, Hazes JM, Ziegler-Heitbrock H W, Nedospasov SA, Breedveld FC, Verweij CL: Functional analysis of a human tumor necrosis factor α (TNF-α) promoter polymorphism related to joint damage in rheumatoid arthritis. Mol Med 1998;4:724-733.
173. Lee GR, Kim ST, Spilianakis CG, Fields PE, Flavell RA: T helper cell differentiation: regulation by cis elements and epigenetics. Immunity 2006;24:369-379.
174. Berger SL: The complex language of chromatin regulation during transcription. Nature 2007;447:407-412.
175. Mellor J, Dudek P, Clynes D: A glimpse into the epi-genetic landscape of gene regulation. Curr Opin Genet Dev 2008;18:116-122.
176. Cedar H, Bergman Y: Linking DNA methylation and histone modification: patterns and paradigms. Nat Rev Genet 2009;10:295-304.
177. Li B, Carey M, Workman JL: The role of chromatin during transcription. Cell 2007;128:707-719.
178. Marmorstein R, Roth SY: Histone acetyltransferases: function, structure, and catalysis. Curr Opin Genet Dev 2001;11:155-161.
179. Shahbazian MD, Grunstein M: Functions of site-specific histone acetylation and deacetylation. Annu Rev Biochem 2007;76:75-100.
180. Lee KK, Workman JL: Histone acetyltransferase complexes: one size doesn't fit all. Nat Rev Mol Cell Biol 2007;8:284-295.
181. Miao F, Gonzalo IG, Lanting L, Natarajan R: In vivo chromatin remodeling events leading to inflammatory gene transcription under diabetic conditions. J Biol Chem 2004;279:18091-18097.
182. Kasper LH, Fukuyama T, Biesen MA, Boussouar F, Tong C, de Pauw A, Murray PJ, van Deursen JM, Brindle PK: Conditional knockout mice reveal distinct functions for the global transcriptional coacti-vators CBP and p300 in T-cell development. Mol Cell Biol 2006;26:789-809.
183. Xu W, Fukuyama T, Ney PA, Wang D, Rehg J, Boyd K, van Deursen JM, Brindle PK: Global transcrip-tional coactivators CREB-binding protein and p300 are highly essential collectively but not individually in peripheral B cells. Blood 2006;107:4407-4416.
184. Ranjbar S, Rajsbaum R, Goldfeld AE: Transactivator of transcription from HIV type 1 subtype E selectively inhibits TNF gene expression via interference with chromatin remodeling of the TNF locus. J Immunol 2006;176:4182-4190.
185. Ramirez-Carrozzi VR, Nazarian AA, Li CC, Gore SL, Sridharan R, Imbalzano AN, Smale ST: Selective and antagonistic functions of SWI/SNF and Mi-2β nucleosome remodeling complexes during an inflammatory response. Genes Dev 2006;20:282-296.
186. Sullivan KE, Reddy AB, Dietzmann K, Suriano AR, Kocieda V P, Stewart M, Bhatia M: Epigenetic regulation of tumor necrosis factor alpha. Mol Cell Biol 2007;27:5147-5160.
187. Garrett S, Dietzmann-Maurer K, Song L, Sullivan KE: Polarization of primary human monocytes by IFN-γ induces chromatin changes and recruits RNA Pol II to the TNF-α promoter. J Immunol 2008; 180:5257-5266.
188. Lee JY, Kim NA, Sanford A, Sullivan KE: Histone acetylation and chromatin conformation are regulated separately at the TNF-α promoter in mono-cytes and macrophages. J Leukoc Biol 2003;73: 862-871.
189. Sullivan KE, Suriano A, Dietzmann K, Lin J, Goldman D, Petri MA: The TNFα locus is altered in monocytes from patients with systemic lupus ery-thematosus. Clin Immunol 2007;123:74-81.
190. Taylor JM, Wicks K, Vandiedonck C, Knight JC: Chromatin profiling across the human tumour necrosis factor gene locus reveals a complex, cell type-specific landscape with novel regulatory elements. Nucleic Acids Res 2008;36:4845-4862.
191. Saccani S, Pantano S, Natoli G: p38-dependent marking of inflammatory genes for increased NF-κB recruitment. Nat Immunol 2002;3:69-75.
192. El Gazzar M, Yoza BK, Chen X, Hu J, Hawkins GA, McCall CE: G9a and HP1 couple histone and DNA methylation to TNFα transcription silencing during endotoxin tolerance. J Biol Chem 2008;283:32198-32208.
193. Kochanek S, Radbruch A, Tesch H, Renz D, Doerfler W: DNA methylation profiles in the human genes for tumor necrosis factors α and β in subpopula-tions of leukocytes and in leukemias. Proc Natl Acad Sci USA 1991;88:5759-5763.
194. Kruys V, Thompson P, Beutler B: Extinction of the tumor necrosis factor locus, and of genes encoding the lipopolysaccharide signaling pathway. J Exp Med 1993;177:1383-1390.
195. Becker C, Barbulescu K, Wirtz S, Meyer zum Buschenfelde KH, Pettersson S, Neurath MF: Constitutive and inducible in vivo protein-DNA interactions at the tumor necrosis factor-α promoter in primary human T lymphocytes. Gene Expr 1999; 8:115-127.
196. Barthel R, Goldfeld AE: T cell-specific expression of the human TNF-α gene involves a functional and highly conserved chromatin signature in intron 3. J Immunol 2003;171:3612-3619.
197. Sung SJ, Walters JA, Hudson J, Gimble JM: Tumor necrosis factor-α mRNA accumulation in human myelomonocytic cell lines. Role of transcriptional regulation by DNA sequence motifs and mRNA stabilization. J Immunol 1991;147:2047-2054.
198. Kuhnert P, Peterhans E, Pauli U: Chromatin structure and DNase I hypersensitivity in the transcriptionally active and inactive porcine tumor necrosis factor gene locus. Nucleic Acids Res 1992;20:1943-1948.
199. Espel E, Garcia-Sanz JA, Aubert V, Menoud V, Sperisen P, Fernandez N, Spertini F: Transcriptional and translational control of TNF-α gene expression in human monocytes by major histocompatibility complex class II ligands. Eur J Immunol 1996;26: 2417-2424.
200. Kwon J, Lee SJ, Benveniste EN: A 3′ cis-acting element is involved in tumor necrosis factor-α gene expression in astrocytes. J Biol Chem 1996;271: 22383-22390.
201. Dekker J: A closer look at long-range chromosomal interactions. Trends Biochem Sci 2003;28:277-280.
202. de Laat W: Long-range DNA contacts: romance in the nucleus? Curr Opin Cell Biol 2007;19:317-320.
203. Carter DR, Eskiw C, Cook PR: Transcription factories. Biochem Soc Trans 2008;36:585-589.
204. O'Sullivan JM, Tan-Wong SM, Morillon A, Lee B, Coles J, Mellor J, Proudfoot NJ: Gene loops juxtapose promoters and terminators in yeast. Nat Genet 2004;36:1014-1018.
205. Drissen R, Palstra RJ, Gillemans N, Splinter E, Grosveld F, Philipsen S, de Laat W: The active spatial organization of the β-globin locus requires the transcription factor EKLF. Genes Dev 2004;18:2485-2490.
206. Spilianakis CG, Lalioti MD, Town T, Lee GR, Flavell RA: Interchromosomal associations between alternatively expressed loci. Nature 2005;435:637-645.
207. Vakoc CR, Letting DL, Gheldof N, Sawado T Bender MA, Groudine M, Weiss MJ, Dekker J, Blobel GA: Proximity among distant regulatory elements at the β-globin locus requires GATA-1 and FOG-1. Mol Cell 2005;17:453-462.
208. Splinter E, Heath H, Kooren J, Palstra RJ, Klous P, Grosveld F, Galjart N, de Laat W: CTCF mediates long-range chromatin looping and local histone modification in the β-globin locus. Genes Dev 2006;20:2349-2354.
209. Kurukuti S, Tiwari VK, Tavoosidana G, Pugacheva E, Murrell A, Zhao Z, Lobanenkov V, Reik W, Ohlsson R: CTCF binding at the H19 imprinting control region mediates maternally inherited higher-order chromatin conformation to restrict enhancer access to Igf2. Proc Natl Acad Sci USA 2006;103:10684-10689.
210. Ling JQ, Li T, Hu JF, Vu TH, Chen HL, Qiu X W, Cherry AM, Hoffman AR: CTCF mediates inter-chromosomal colocalization between Igf2/H19 and Wsb1/Nf1. Science 2006;312:269-272.
211. Cockerill PN: NFAT is well placed to direct both enhancer looping and domain-wide models of enhancer function. Sci Signal 2008;1:pe15.
212. Murrell A, Heeson S, Reik W: Interaction between differentially methylated regions partitions the imprinted genes Igf2 and H19 into parent-specific chromatin loops. Nat Genet 2004;36:889-893.
213. Deakin JE, Papenfuss AT, Belov K, Cross JG, Coggill P, Palmer S, Sims S, Speed T P, Beck S, Graves JA: Evolution and comparative analysis of the MHC class III inflammatory region. BMC Genomics 2006; 7:281.
214. Gupta D, Jin Y P, Dziarski R: Peptidoglycan induces transcription and secretion of TNF-α and activation of lyn, extracellular signal-regulated kinase, and rsk signal transduction proteins in mouse macrophages. J Immunol 1995;155:2620-2630.
215. Shapira L, Takashiba S, Amar S, Van Dyke TE: Porphyromonas gingivalis lipopolysaccharide stimulation of human monocytes: dependence on serum and CD14 receptor. Oral Microbiol Immunol 1994; 9:112-117.
216. English BK, Patrick CC, Orlicek SL, McCordic R, Shenep JL: Lipoteichoic acid from viridans streptococci induces the production of tumor necrosis factor and nitric oxide by murine macrophages. J Infect Dis 1996;174:1348-1351.
217. Sato S, Nomura F, Kawai T, Takeuchi O, Muhlradt PF, Takeda K, Akira S: Synergy and cross-tolerance between toll-like receptor (TLR) 2-and TLR4-mediated signaling pathways. J Immunol 2000; 165:7096-7101.
218. Bondeson J, Sundler R: Auranofin inhibits the induction of interleukin 1 beta and tumor necrosis factor α mRNA in macrophages. Biochem Pharmacol 1995;50:1753-1759.
219. Wong GH, Goeddel DV: Tumour necrosis factors α and β inhibit virus replication and synergize with interferons. Nature 1986;323:819-822.
220. Beutler B, Krochin N, Milsark I W, Luedke C, Cerami A: Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science 1986;232:977-980.
221. Goeddel D V, Aggarwal BB, Gray P W, Leung D W, Nedwin GE, Palladino MA, Patton JS, Pennica D, Shepard HM, Sugarman BJ, Wong GHW: Tumor necrosis factors: gene structure and biological activities. Cold Spring Harbor Symp Quant Biol 1986;60: 597-609.
222. Perera PY, Manthey CL, Stutz PL, Hildebrandt J, Vogel SN: Induction of early gene expression in murine macrophages by synthetic lipid A analogs with differing endotoxic potentials. Infect Immun 1993;61:2015-2023.
223. Manthey CL, Brandes ME, Perera PY, Vogel SN: Taxol increases steady-state levels of lipopolysac-charide-inducible genes and protein-tyrosine phos-phorylation in murine macrophages. J Immunol 1992;149:2459-2465.
224. Pope BL, MacIntyre J P, Kimball E, Lee S, Zhou L, Taylor GR, Goodman MG: The immunostimula-tory compound 7-allyl-8-oxoguanosine (loxoribine) induces a distinct subset of murine cytokines. Cell Immunol 1995;162:333-339.
225. Stacey KJ, Sweet MJ, Hume DA: Macrophages ingest and are activated by bacterial DNA. J Immunol 1996;157:2116-2122.
226. Megyeri K, Au WC, Rosztoczy I, Raj NB, Miller RL, Tomai MA, Pitha PM: Stimulation of interferon and cytokine gene expression by imiquimod and stimulation by Sendai virus utilize similar signal trans-duction pathways. Mol Cell Biol 1995;15: 2207-2218.
227. Le Contel C, Temime N, Charron DJ, Parant MA: Modulation of lipopolysaccharide-induced cytokine gene expression in mouse bone marrow-derived macrophages by muramyl dipeptide. J Immunol 1993;150:4541-4549.
228. Anegón I, Cuturi MC, Trinchieri G, Perussia B: Interaction of Fc receptor (CD16) ligands induces transcription of interleukin 2 receptor (CD25) and lymphokine genes and expression of their products in human natural killer cells. J Exp Med 1988; 167:452-472.
229. Kovacs EJ, Beckner SK, Longo DL, Varesio L, Young HA: Cytokine gene expression during the generation of human lymphokine-activated killer cells: early induction of interleukin 1β by interleukin 2. Cancer Res 1989;49:940-944.
230. Collart MA, Belin D, Vassalli JD, de Kossodo S, Vassalli P: γ-Interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors. J Exp Med 1986; 164:2113-2118.
231. Cannistra SA, Rambaldi A, Spriggs DR, Herrmann F, Kufe D, Griffin JD: Human granulocyte-mac-rophage colony-stimulating factor induces expression of the tumor necrosis factor gene by the U937 cell line and by normal human monocytes. J Clin Invest 1987;79:1720-1728.
232. Spriggs D, Imamura K, Rodriguez C, Horiguchi J, Kufe DW: Induction of tumor necrosis factor expression and resistance in a human breast tumor cell line. Proc Natl Acad Sci USA 1987;84:6563-6566.
233. Collart MA, Belin D, Vassalli JD, Vassalli P: Modulations of functional activity in differentiated macrophages are accompanied by early and transient increase or decrease in c-fos gene transcription. J Immunol 1987;139:949-955.
234. Trede NS, Geha RS, Chatila T: Transcriptional activation of IL-1β and tumor necrosis factor-α genes by MHC class II ligands. J Immunol 1991;146:2310-2315.
235. Sung SJ, Walters JA, Fu SM: Stimulation of tumor necrosis factor-α production in human monocytes by inhibitors of protein phosphatase 1 and 2A. J Exp Med 1992;176:897-901.
236. Rieckmann P, Thevenin C, Kehrl JH: Okadaic acid is a potent inducer of AP-1, NF-κB, and tumor necrosis factor-α in human B lymphocytes. Biochem Biophys Res Commun 1992;187:51-57.
237. Kock A, Schwarz T, Kirnbauer R, Urbanski A, Perry P, Ansel JC, Luger TA: Human keratinocytes are a source for tumor necrosis factor α: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J Exp Med 1990;172:1609-1614.
238. Hallahan DE, Spriggs DR, Beckett MA, Kufe DW, Weichselbaum RR: Increased tumor necrosis factor-α mRNA after cellular exposure to ionizing radiation. Proc Natl Acad Sci USA 1989;86:10104-10107.
239. Guha M, Bai W, Nadler JL, Natarajan R: Molecular mechanisms of tumor necrosis factor α gene expression in monocytic cells via hyperglycemia-induced oxidant stress-dependent and-independent pathways. J Biol Chem 2000;275:17728-17739.
240. Piguet PF, Collart MA, Grau GE, Sappino AP, Vassalli P: Requirement of tumour necrosis factor for development of silica-induced pulmonary fibro-sis. Nature 1990;344:245-247.
241. Ehlers S, Mielke MEA, Blankenstein T, Hahn H: Kinetic analysis of cytokine gene expression in the livers of naive and immune mice infected with Listeria monocytogenes. J Immunol 1992;149:3016-3022.
242. Poston RM, Kurlander RJ: Cytokine expression in vivo during murine listeriosis. Infection with live, virulent bacteria is required for monokine and lym-phokine messenger RNA accumulation in the spleen. J Immunol 1992;149:3040-3044.
243. Barnes PF, Fong SJ, Brennan PJ, Twomey PE, Mazumder A, Modlin RL: Local production of tumor necrosis factor and IFN-γ in tuberculous pleuritis. J Immunol 1990;145:149-154.
244. Rugo HS, O'Hanley P, Bishop AG, Pearce MK, Abrams JS, Howard M, O'Garra A: Local cytokine production in a murine model of Escherichia coli pyelonephritis. J Clin Invest 1992;89:1032-1039.
245. Berent SL, Torczynski RM, Bollon AP: Sendai virus induces high levels of tumor necrosis factor mRNA in human peripheral blood leukocytes. Nucleic Acids Res 1986;14:8997-9015.
246. Dudding L, Haskill S, Clark BD, Auron PE, Sporn S, Huang ES: Cytomegalovirus infection stimulates expression of monocyte-associated mediator genes. J Immunol 1989;143:3343-3352.
247. + T cells stimulated by Plasmodium falciparum. Parasite Immunol 1995;17:413-423.
248. Van Voorhis WC: Coculture of human peripheral blood mononuclear cells with Trypanosoma cruzi leads to proliferation of lymphocytes and cytokine production. J Immunol 1992;148:239-248.
249. Wynn TA, Oswald I P, Eltoum IA, Caspar P, Lowenstein CJ, Lewis FA, James SL, Sher A: Elevated expression of Th1 cytokines and nitric oxide syn-thase in the lungs of vaccinated mice after challenge infection with Schistosoma mansoni. J Immunol 1994;153:5200-5209.
250. Suriano AR, Sanford AN, Kim N, Oh M, Kennedy S, Henderson MJ, Dietzmann K, Sullivan KE: GCF2/ LRRFIP1 represses tumor necrosis factor alpha expression. Mol Cell Biol 2005;25:9073-9081.
251. Schreiber J, Jenner RG, Murray HL, Gerber GK, Gifford DK, Young RA: Coordinated binding of NF-κB family members in the response of human cells to lipopolysaccharide. Proc Natl Acad Sci USA 2006;103:5899-5904.
252. Amar S, Zhou Q, Shaik-Dasthagirisaheb Y, Leeman S: Diet-induced obesity in mice causes changes in immune responses and bone loss manifested by bacterial challenge. Proc Natl Acad Sci USA 2007; 104:20466-20471.
253. Cvoro A, Tzagarakis-Foster C, Tatomer D, Paruthiyil S, Fox MS, Leitman DC: Distinct roles of unliganded and liganded estrogen receptors in transcriptional repression. Mol Cell 2006;21:555-564.
254. Yang YJ, Chen W, Carrigan SO, Chen WM, Roth K, Akiyama T, Inoue J, Marshall JS, Berman JN, Lin TJ: TRAF6 specifically contributes to FcεRI-mediated cytokine production but not mast cell degranula-tion. J Biol Chem 2008;283:32110-32118.
255. Wang J, Wang X, Hussain S, Zheng Y, Sanjabi S, Ouaaz F, Beg AA: Distinct roles of different NF-κB subunits in regulating inflammatory and T cell stimulatory gene expression in dendritic cells. J Immunol 2007;178:6777-6788.
256. Sanjabi S, Hoffmann A, Liou HC, Baltimore D, Smale ST: Selective requirement for c-Rel during IL-12 P40 gene induction in macrophages. Proc Natl Acad Sci USA 2000;97:12705-12710.
257. Gadjeva M, Tomczak MF, Zhang M, Wang YY, Dull K, Rogers AB, Erdman SE, Fox JG, Carroll M, Horwitz BH: A role for NF-κB subunits p50 and p65 in the inhibition of lipopolysaccharide-induced shock. J Immunol 2004;173:5786-5793.
258. Gerondakis S, Strasser A, Metcalf D, Grigoriadis G, Scheerlinck J Y, Grumont RJ: Rel-deficient T cells exhibit defects in production of interleukin 3 and granulocyte-macrophage colony-stimulating factor. Proc Natl Acad Sci USA 1996;93:3405-3409.
259. Caamaño J, Alexander J, Craig L, Bravo R, Hunter CA: The NF-κB family member RelB is required for innate and adaptive immunity to Toxoplasma gon-dii. J Immunol 1999;163:4453-4461.
260. Franzoso G, Carlson L, Xing L, Poljak L, Shores E W, Brown KD, Leonardi A, Tran T, Boyce BF, Siebenlist U: Requirement for NF-κB in osteoclast and B-cell development. Genes Dev 1997;11:3482-3496.
261. Iotsova V, Caamaño J, Loy J, Yang Y, Lewin A, Bravo R: Osteopetrosis in mice lacking NF-κB1 and NF-κB2. Nat Med 1997;3:1285-1289.